Breaking News

MediPharm Labs Receives Canadian GMP Pharmaceutical DEL

License can be used for manufacturing, testing and sale of APIs and pharmaceutical drug products containing cannabis.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MediPharm Labs Corp., a pharma company specialized in research-driven development and manufacturing of cannabis API and finished products, received a Drug Establishment License (DEL) issued by Health Canada in accordance with the Food and Drugs Act and Regulations. The DEL serves to confirm compliance to Good Manufacturing Practice (GMP) standards.   The DEL is a first of its kind license for cannabis manufacturing in North America. A Canadian GMP DEL complements MediPharm Labs’ existing Austr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters